Globus Medical: The Dip Makes It Cheaper, Not Different (NYSE:GMED)
· seekingalpha.com
Globus stock slid 8.5% but remains a Hold. See why H2 growth may slow, FCF margins normalize, and recruiting/M&A drive growth—read the analysis.
Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions...